AndrewESchadeMD

PubMed

• 1 citations
  Pathologist-trained machine learning classifiers developed to quantitate celiac disease features differentiate endoscopic biopsies according to modified marsh score an...
  Aaron M Gruver, Haiyan Lu, Xiaoxian Zhao, Angie D Fulford, Michael D Soper, Darryl Ballard, Jeffrey C Hanson, Andrew E Schade, Eric D Hsi, Klaus Gottlieb, Kelly M Cred...> ;Diagnostic Pathology. 2023 Nov 11
• 51 citations
  Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Cl...
  Michael J Pontecorvo, Ming Lu, Samantha C Burnham, Andrew E Schade, Jeffrey L Dage, Sergey Shcherbinin, Emily C Collins, John R Sims, Mark A Mintun> ;JAMA Neurology. 2022 Dec 1
• 19 citations
  A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic...
  Michael Dougan, Masoud Azizad, Bharat Mocherla, Robert L. Gottlieb, Peter Chen, Corey Hebert, Russell Perry, Joseph Boscia, Barry Heller, Jason Morris, Chad Crystal, A...> ;Clinical Infectious Diseases. 2021 Oct 28
• 403 citations
  Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
  Michael Dougan, Ajay Nirula, Masoud Azizad, Bharat Mocherla, Robert L. Gottlieb, Peter Chen, Corey Hebert, Russell Perry, Joseph Boscia, Barry Heller, Jason Morris, Ch...> ;The New England Journal of Medicine. 2021 Jul 14
• 3 citations
  Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization.
  Jessica A. Roseberry Baker, Anthony N. Sireci, Narasimha Marella, Holly Kay Cannon, Tyler J Marquart, Timothy R. Holzer, Leslie O'Neill Reising, Joel D. Cook, Sameera ...> ;Archives of Pathology & Laboratory Medicine. 2021 Jul 7
• 131 citations
  Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial
  Myron S. Cohen, Ajay Nirula, Mark J. Mulligan, Richard M. Novak, Mary A. Marovich, Catherine Yen, Alexander Stemer, Stockton Mayer, David A. Wohl, Blair Brengle, Brian...> ;JAMA. 2021 Jul 6
• 7 citations
  Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit.
  Jorge J. Canas, Michelle C. Starr, Jenaya Hooks, Samuel Arregui, Amy C. Wilson, Aaron E. Carroll, Vijay Saxena, Fatima Amanat, Florian Krammer, Jeffrey Fill, Andrew E....> ;Kidney International. 2021 Feb 1
• 641 citations
  Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
  Robert L. Gottlieb, Ajay Nirula, Peter Chen, Joseph Boscia, Barry Heller, Jason Morris, Gregory D. Huhn, Jose Cardona, Bharat Mocherla, Valentina Stosor, Imad Shawa, P...> ;JAMA. 2021 Feb 16
• 827 citations
  SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
  Peter Chen, Ajay Nirula, Barry Heller, Robert L. Gottlieb, Joseph Boscia, Jason Morris, Gregory D. Huhn, Jose Cardona, Bharat Mocherla, Valentina Stosor, Imad Shawa, A...> ;The New England Journal of Medicine. 2021 Jan 21
• 16 citations
  Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer
  Daniel C. Liebler, Timothy R. Holzer, Alexander Haragan, Ryan D. Morrison, Leslie O'Neill Reising, Bradley L. Ackermann, Jeff A. Fill, Andrew E. Schade, Aaron M Gruver> ;Scientific Reports. 2020 Jun 17
• 45 citations
  The Cancer Immunotherapy Biomarker Testing Landscape.
  Eric E Walk, Sophia L Yohe, Amy Beckman, Andrew Schade, Mary M. Zutter, John D. Pfeifer, Anna B Berry> ;Archives of Pathology & Laboratory Medicine. 2020 Jun 1
• 16 citations
  Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.
  Phillip G. Febbo, Anne-Marie Martin, Howard I. Scher, J. Carl Barrett, Julia A. Beaver, Paul J. Beresford, Gideon M. Blumenthal, Kelli Bramlett, Carolyn Compton, Ryan ...> ;Clinical Pharmacology and Therapeutics. 2020 Apr 1
• 44 citations
  A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer.
  Ryan J. Sullivan, Antoine Hollebecque, Keith T. Flaherty, Geoffrey I. Shapiro, Jordi Rodon Ahnert, Michael Millward, Wei Zhang, Ling Gao, Amanda K. Sykes, Melinda D. W...> ;Molecular Cancer Therapeutics. 2020 Feb 1
• 14 citations
  Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry.
  Alexander Haragan, Daniel C. Liebler, Dimple M Das, Michael D Soper, Ryan D. Morrison, Robbert J.C. Slebos, Bradley L. Ackermann, Jeff A. Fill, Andrew E. Schade, John ...> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 2020 Jan 2
• 61 citations
  Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine.
  Carolyn C. Compton, James A. Robb, Matthew W. Anderson, Anna B. Berry, George G. Birdsong, Kenneth J. Bloom, Philip A. Branton, Jessica W. Crothers, Allison M. Cushman...> ;Archives of Pathology & Laboratory Medicine. 2019 Jul 22
• 19 citations
  Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies
  Aejaz Nasir, Timothy R. Holzer, Mia Chen, Michael Z. Man, Andrew E. Schade> ;Cancer Cell International. 2017 May 19
• 11 citations
  Variability in Platelet-Derived Growth Factor Receptor Alpha Antibody Specificity May Impact Clinical Utility of Immunohistochemistry Assays.
  Timothy R. Holzer, Leslie O'Neill Reising, Kelly M. Credille, Andrew E. Schade, Gerard J. Oakley> ;The Journal of Histochemistry and Cytochemistry. 2016 Nov 11
• 4 citations
  Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma.
  Timothy R. Holzer, Angie D. Fulford, Leslie O'Neill Reising, Drew M. Nedderman, Xuekui Zhang, Laura E. Benjamin, Andrew E. Schade, Aejaz Nasir> ;Anticancer Research. 2016 Jul 1
• 12 citations
  Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.
  Aejaz Nasir, Leslie O'Neill Reising, Drew M. Nedderman, Angie D. Fulford, Mark T. Uhlik, Laura E. Benjamin, Andrew E. Schade, Timothy R. Holzer> ;Anticancer Research. 2016 Jun 1
• 459 citations
  Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors
  Amita Patnaik, Lee S. Rosen, Sara M. Tolaney, Anthony W. Tolcher, Jonathan W. Goldman, Leena Gandhi, Kyriakos P. Papadopoulos, Muralidhar Beeram, Drew W. Rasco, John H...> ;Cancer Discovery. 2016 May 23
• 2 citations
  Advanced Companion Diagnostics Facilities: Opportunity Favors the Prepared Laboratory
  Aaron M Gruver, Andrew E. Schade> ;Archives of Pathology & Laboratory Medicine. 2015 Sep 28
• 14 citations
  Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth facto...
  Aaron M Gruver, Ling Liu, Peter Edward Vaillancourt, Sau-Chi B. Yan, Joel D. Cook, Jessica A. Roseberry Baker, Erin M Felke, Megan E Lacy, Christophe C. Marchal, Hadri...> ;Histopathology. 2014 Dec 1
• 38 citations
  Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung
  Timothy R. Holzer, Angie D. Fulford, Drew M. Nedderman, Tara S. Umberger, Rebecca R. Hozak, Adarsh Joshi, Symantha Melemed, Laura E. Benjamin, Gregory D. Plowman, Andr...> ;Plos One. 2013 Nov 14
• 67 citations
  Circulating Human Hepcidin-25 Concentrations Display a Diurnal Rhythm, Increase with Prolonged Fasting, and Are Reduced by Growth Hormone Administration
  Jason S. Troutt, Mats Rudling, Lena Persson, Lars Ståhle, Bo Angelin, Anthony M. Butterfield, Andrew E. Schade, Guoqing Cao, Robert J. Konrad> ;Clinical Chemistry. 2012 Aug 1
• 252 citations
  Considerations in the development of circulating tumor cell technology for clinical use
  David R. Parkinson, Nicholas C. Dracopoli, Brenda Gumbs Petty, Carolyn C. Compton, Massimo Cristofanilli, Albert B. Deisseroth, Daniel F. Hayes, Gordon Kapke, Prasanna...> ;Journal of Translational Medicine. 2012 Jul 2
• Join now to see all